ArticleOncoimmunology2021

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers.

Kwang-Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.